Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Sunday, 30 April 2017 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2017 Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017, in Seattle.
Antiretroviral Therapy and Treatment Strategies
- Several New Candidates in HIV Drug Pipeline Discussed at Conference
- Dolutegravir Monotherapy Fails to Maintain Viral Suppression
- Integrase Inhibitors May Increase Risk of IRIS in Late Presenters for HIV Treatment
- New HIV Capsid Inhibitors Show High Potency and Prolonged Activity in Early Studies
- Treatment-as-Prevention Study Sees Substantial Drug Resistance, but No Impact on HIV Therapy
- Monoclonal Antibodies Show Promise for HIV+ People with Few Treatment Options
- New NNRTI Doravirine Shows Good Efficacy in Phase 3 Study
- Efavirenz/Tenofovir/Emtricitabine Less Likely to Cause Adverse Birth Outcomes
- Dual Antiretroviral Regimen Maintains Durable HIV Suppression after Switch
- Integrase Inhibitor Bictegravir Matches Dolutegravir for First-Line HIV Treatment
- Infants Treated Within Days of Birth Can Clear HIV Reservoir Rapidly
HIV Cure Research
- Timothy Brown, the Berlin Patient, Celebrates a Decade Cured of HIV
- How Does Vedolizumab Antibody Therapy Lead to Sustained Viral Remission?
- Bone Marrow Transplant Patient Off ART for 288 Days Without HIV Rebound
- Spanish HIV Vaccine Induces Control Off ART in Nearly 40% of Recipients
- Infants Treated Within Days of Birth Can Clear HIV Reservoir Rapidly
HIV Prevention
- Bacterial Vaginosis Does Not Affect Efficacy of Oral PrEP in Women
- STI Rates Among PrEP Users Are High, But Evidence that PrEP Increases Them Is Inconclusive
- Unique Case of PrEP Failure Without Drug Resistance Reported in Amsterdam
- STI Prophylaxis in PrEP Users Reduces Syphilis and Chlamydia, but Not Gonorrhea
HIV-Related Conditions and Complications
- Better Depression Care Could Improve Outcomes for HIV Treatment Programs
- Long-Term Darunavir/Ritonavir Modestly Increases Risk of Cardiovascular Disease
- Bone Density Improves in People Who Switch from Tenofovir DF to Tenofovir Alafenamide
- Studies Look at Brain and Cognitive Changes in People with HIV As They Age
- Stopping Smoking Cuts Risk of Some Cancers Quickly in People with HIV
- Treatment or Watchful Waiting for Cervical Abnormalities in Women with HIV?
HIV Epidemiology and Access to Care
- HIV's Milder Cousin May Be Less Mild than Previously Thought
- Accelerated Linkage to HIV Care Improves Retention by a Third
- Treat and Treat Study Shows Second Phase Is Finding More People with HIV
- Finding Men with HIV -- and Keeping Them in Treatment
- 1 in 5 HIV+ Men in U.K. Who Say They Are Heterosexual Caught HIV from Another Man
- Simple Risk Score Can Identify Gay Men Who May Have Acute HIV Infection
- Peer Navigators Improve Linkage to HIV Care and Retention in South African Study
- Point-of-Care Testing Improves Infant HIV Diagnosis Rate, Treatment, and Retention
- Will There Be a New Wave of HIV Among People Who Inject Drugs in the U.S.?
- How Should HIV Self-Testing Be Provided?
- Time with Transmissible HIV Viral Load Has Fallen By Three-Quarters Since 2000
- Science, Community, and Political Will Can End HIV Epidemic, Says New York Commissioner
- New HIV Infections Fall in the U.S. but Disparities Remain
- Changes In Viral Suppression Over Time Reveal Disparities in HIV Care
- A Combination of Factors Has Reduced HIV Infections in Hard-Hit Part of Africa
Hepatitis C and HIV/HCV Coinfection
- Hepatitis C Treatment Can Be Provided Successfully at Syringe Exchange Sites
- Higher than Expected HCV Prevalence Among HIV-Negative Gay Men in Amsterdam PrEP Program
- DAA Therapy Cures HIV/HCV Coinfected People with Decompensated Cirrhosis or Transplants
- Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?
- Glecaprevir/Pibrentasvir for HCV Can Be Safely Administered with Common Antiretrovirals
- New HCV Infections Among HIV+ Gay Men Drop By Half After DAA Roll-Out in Netherlands
Tuberculosis
- Prednisone Reduces Risk of Developing TB-IRIS after Starting Antiretroviral Treatment
- Isoniazid Preventive Therapy for TB Reduces Risk of Death for People Living with HIV
- Triple Tuberculosis Regimen Beats XDR-TB in First Trial